| Title : Delta9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice - Wiebelhaus_2015_J.Pharmacol.Exp.Ther_352_195 |
| Author(s) : Wiebelhaus JM , Grim TW , Owens RA , Lazenka MF , Sim-Selley LJ , Abdullah RA , Niphakis MJ , Vann RE , Cravatt BF , Wiley JL , Negus SS , Lichtman AH |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 352 :195 , 2015 |
| Abstract : Wiebelhaus_2015_J.Pharmacol.Exp.Ther_352_195 |
| ESTHER : Wiebelhaus_2015_J.Pharmacol.Exp.Ther_352_195 |
| PubMedSearch : Wiebelhaus_2015_J.Pharmacol.Exp.Ther_352_195 |
| PubMedID: 25398241 |
Wiebelhaus JM, Grim TW, Owens RA, Lazenka MF, Sim-Selley LJ, Abdullah RA, Niphakis MJ, Vann RE, Cravatt BF, Wiley JL, Negus SS, Lichtman AH (2015)
Delta9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice
Journal of Pharmacology & Experimental Therapeutics
352 :195
Wiebelhaus JM, Grim TW, Owens RA, Lazenka MF, Sim-Selley LJ, Abdullah RA, Niphakis MJ, Vann RE, Cravatt BF, Wiley JL, Negus SS, Lichtman AH (2015)
Journal of Pharmacology & Experimental Therapeutics
352 :195